Abstract
Three patients developed a periorbital eczematous eruption during topical treatment with β-blocker eyedrops for glaucoma. All patients were patch tested with their eyedrops and their single constituents. In all patients, personal eyedrops produced a positive patch test; we found positive reactions to befunolol 0.25% in water, 0.5% in water, and 1% in water. The third patient also used timolol eyedrops and showed a positive patch test to timolol maleate 0.5% aqueous.
| Original language | English |
|---|---|
| Pages (from-to) | 102-103 |
| Number of pages | 2 |
| Journal | American Journal of Contact Dermatitis |
| Volume | 5 |
| Issue number | 2 |
| State | Published - Jun 1 1994 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Dermatology
Cite this
Allergic contact dermatitis caused by β-blockers in eyedrops. / Vincenzi, Colombina; Ricci, Cinzia; Peluso, Anna Maria; Tosti, Antonella.
In: American Journal of Contact Dermatitis, Vol. 5, No. 2, 01.06.1994, p. 102-103.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Allergic contact dermatitis caused by β-blockers in eyedrops
AU - Vincenzi, Colombina
AU - Ricci, Cinzia
AU - Peluso, Anna Maria
AU - Tosti, Antonella
PY - 1994/6/1
Y1 - 1994/6/1
N2 - Three patients developed a periorbital eczematous eruption during topical treatment with β-blocker eyedrops for glaucoma. All patients were patch tested with their eyedrops and their single constituents. In all patients, personal eyedrops produced a positive patch test; we found positive reactions to befunolol 0.25% in water, 0.5% in water, and 1% in water. The third patient also used timolol eyedrops and showed a positive patch test to timolol maleate 0.5% aqueous.
AB - Three patients developed a periorbital eczematous eruption during topical treatment with β-blocker eyedrops for glaucoma. All patients were patch tested with their eyedrops and their single constituents. In all patients, personal eyedrops produced a positive patch test; we found positive reactions to befunolol 0.25% in water, 0.5% in water, and 1% in water. The third patient also used timolol eyedrops and showed a positive patch test to timolol maleate 0.5% aqueous.
UR - http://www.scopus.com/inward/record.url?scp=38149148319&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=38149148319&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:38149148319
VL - 5
SP - 102
EP - 103
JO - Dermatitis
JF - Dermatitis
SN - 1710-3568
IS - 2
ER -